A. Kunová

发表

Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients.

S. Špánik, J. Trupl, G. Kovacicova, 2001, Scandinavian journal of infectious diseases.

Low incidence of quinolone resistance in gram-negative bacteria after five-years use of ofloxacin in prophylaxis during afebrile neutropenia.

J. Trupl, V. Krčméry, A. Kunová, 1996, The Journal of hospital infection.

Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study.

S. Špánik, J. Trupl, V. Krčméry, 1998, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.

V. Rusňáková, S. Špánik, J. Trupl, 1997, Scandinavian journal of infectious diseases.

Documented fungal infections after prophylaxis or therapy with wide spectrum antibiotics: relationship between certain fungal pathogens and particular antimicrobials?

V. Krčméry, A. Kunová, M. Sulcova, 1999, Journal of chemotherapy.

Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.

E. Kaiserova, J. Trupl, V. Krčméry, 1998, Journal of chemotherapy.

Fungaemia due to thermophilic cryptococci: 3 cases of Cryptococcus laurentii bloodstream infections in cancer patients receiving antifungals.

V. Krčméry, A. Kunová, 1999, Scandinavian journal of infectious diseases.

NosocomialCryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole

J. Mardiak, V. Krčméry, A. Kunová, 1997, Infection.

Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol

S. Špánik, J. Trupl, F. Mateička, 1999, Supportive Care in Cancer.

Nosocomial candidaemias due to species other than Candida albicans in cancer patients

J. Šufliarský, Ľ. Ševčíková, J. Mardiak, 1999, Supportive Care in Cancer.

Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome.

S. Špánik, P. Pichna, J. Trupl, 1997, Scandinavian journal of infectious diseases.

Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.

J. Šufliarský, J. Mardiak, S. Špánik, 1997, Journal of medical microbiology.

Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.

S. Špánik, P. Pichna, J. Trupl, 1997, Microbial drug resistance.

Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes.

S. Špánik, P. Pichna, J. Trupl, 1996, International journal of antimicrobial agents.

Invasive infections due to Clavispora lusitaniae.

V Krcmery, F Mateicka, S Grausova, 1999, FEMS immunology and medical microbiology.

Fungaemia due to Fusarium spp. in cancer patients.

J. Šufliarský, J. Mardiak, S. Špánik, 1997, The Journal of hospital infection.

FatalTrichosporon pullulans breakthrough fungemia in cancer patients: Report of three patients who failed on prophylaxis with itraconazole

J. Šufliarský, S. Špánik, J. Godal, 1996, Infection.

First report of catheter associated Trichosporon pullulans breakthrough fungaemia in a cancer patient.

J. Šufliarský, V. Krčméry, A. Kunová, 1996, The Journal of infection.

First report of Prototheca wickerhami algaemia in an adult leukemic patient.

S. Špánik, V. Krčméry, A. Kunová, 1996, Journal of chemotherapy.

Report of catheter-associatedTrichosporon pullulons break-through fungemia in a cancer patient

J. Šufliarský, V. Krčméry, A. Kunová, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Successful treatment of catheter-associated fungemia due toCandida krusei andTrichosporon beigelii in a leukemic patient receiving prophylactic itraconazole

S. Špánik, V. Krčméry, A. Kunová, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.

I. Gould, K. Milne, A. Kunová, 1998, Journal of chemotherapy.

Breakthrough fungemia appearing during empiric therapy with amphotericin B.

S. Špánik, J. Trupl, V. Krčméry, 1997, Chemotherapy.

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.

S. Špánik, J. Trupl, V. Krčméry, 1998, The Journal of antimicrobial chemotherapy.

Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia.

J. Šufliarský, J. Mardiak, S. Špánik, 1998, International journal of antimicrobial agents.

Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.

S. Špánik, J. Trupl, V. Krčméry, 1999, Journal of chemotherapy.

BACTEREMIA DUE TO CIPROFLOXACIN-RESISTANT PSEUDOMONAS AERUGINOSA IN CANCERPATIENTS : RISK FACTORS FOR RESISTANCE AND OUTCOME OF 25 EPISODES. A CASE-C ONTROL STUDY

J. Trupl, V. Krčméry, A. Kunová, 1999 .

Antibiotic Use and Development of Resistance in Blood Culture Isolates: 8 Years of Experience from a Cancer Referral Center

I. Gould, R. Babela, J. Trupl, 2001, Journal of chemotherapy.

Bacteremia due to Enterobacter spp. in cancer patients--analysis of 51 episodes.

S. Špánik, P. Pichna, J. Trupl, 1997, International journal of antimicrobial agents.

Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.

S. Špánik, P. Pichna, J. Trupl, 1997, Acta oncologica.

Candida famata Fungemia in a Cancer Patient: Case Report

V. Krčméry, A. Kunová, 2000, Journal of chemotherapy.

Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.

S. Špánik, Ľ. Drgoňa, V. Krčméry, 1996, International journal of clinical pharmacology research.

Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.

S. Špánik, P. Pichna, Ľ. Drgoňa, 1996, Neoplasma.

Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species.

J. Trupl, V. Krčméry, A. Kunová, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Candida glabrata fungemia in a tertiary cancer institution in Slovakia

S. Špánik, A. Kunová, M. Sulcova, 1999, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study

S. Špánik, J. Trupl, A. Kunová, 1998, Journal of chemotherapy.

Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes

J. Šufliarský, V. Rusňáková, J. Mardiak, 1998, Supportive Care in Cancer.

Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole.

J. Šufliarský, S. Špánik, Ľ. Drgoňa, 1995, Chemotherapy.